Alector Inc. (ALEC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Alector Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$2.25
+7.14% today
Market cap
$311M
Overall quality
22/100
Kronos AI 30-day
−13.7%
1 of 8 simulated paths end higher
Alector Inc. (ALEC) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $311M. It trades at $2.25, up 7.14% today. Its overall quality score is 22 out of 100, ranked against the whole US market. 7 analysts' average target of $3.90 implies +73.3% from today's price. Kronos AI's 30-day forecast is −13.7% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.90 |
| Low – high | $1.00 – $8.00 |
| Analysts | 7 |
| Upside to average | +73.3% |
Kronos AI 30-day forecast
| Expected close | $1.81 (−13.7%) |
| Likely range | −18.8% … −2.8% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
| Profitability | 3 |
| Solvency | 49 |
| Growth | 15 |
| Overall | 22 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.